Private Equity Investor PLCPress Releases
About the Fund
Our Portfolio
Company Personnel
Annual Report
Interim Report
Regulatory News
General Meetings
Press Releases
Articles of Association
Share Price
Home
4th Floor, 23 Bentinck Street, London W1U 2EZ - Tel +44 (0)20 7563 1630 - Fax +44 (0)20 7486 4534
Net Asset Value 228.06p/341.20¢ inc. current period deficit; 228.73p/342.20¢ exc. current period deficit
per ordinary share at 30 June 2010 incorporating unaudited Revenue Reserves to 31 May 2010 (exchange rate, £1=US$1.4961).
For Limited Partnerships Revaluations see Our Portfolio.
Registered office
Beaufort House
51 New North Road
Exeter, EX4 4EP
Company Number
3912487 – England & Wales


HACKER SAFE certified sites prevent over 99.9% of hacker crime.
Connector
Opening the doors to world class opportunity at the venture stage
Linking IT investment in the UK and USA

2 JANUARY 2009

Private Equity Investor plc – Voting Rights and Capital

In conformity with the provisions of the Financial Services Authority's Disclosure and Transparency Rules, the Company notifies the market of the following:

As at 31 December 2008, the issued share capital and voting rights of the Company is as follows:

Class of share Total number of shares in circulation Number of voting rights attached to each share Total number of voting rights for each class of share in circulation Number of shares held in treasury (carrying no voting rights attached until issued) Total number of shares in issue for each class
Ordinary 0.01p Shares 34,953,675 1 34,953,675 nil 34,953,675

The above figure may be used by shareholders as a denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, the Company under the FSA’s Disclosure and Transparency Rules.

2 January 2009


Notes to editors
The Company seeks to achieve substantial capital appreciation by investing in emerging growth companies through specialised US venture capital funds focused on the information technology, biotechnology and healthcare sectors.


Return to Press Release Index